Transgenomic's IPO

Transgenomic raised a round of funding on July 24, 2000. Investors include Public.

Transgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic…

Articles about Transgenomic's IPO: